{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:24:38Z","timestamp":1791559478366,"version":"4.3.4"},"reference-count":10,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with high recurrence risk and limited long-term survival, particularly after metastatic spread. Oncocytic ACC is an uncommon variant that may behave more indolently but can still recur. We report a 30-year-old Filipina with a nonfunctioning oncocytic ACC initially treated with laparoscopic adrenalectomy (R1 margin; Ki-67 10%-20%). She developed local recurrence at 2.5 years, underwent open resection (R1; Ki-67 20%) followed by adjuvant tumor-bed radiotherapy and mitotane, which was discontinued because of intolerance and cost. After a lapse in follow-up, she developed a solitary hepatic metastasis resected with negative margins; planned etoposide, doxorubicin, and cisplatin chemotherapy was stopped after 3 cycles because of ototoxicity. Subsequent surveillance identified a paraumbilical nodal\/subcutaneous metastasis resected with negative margins. More than 10 years from diagnosis, she remains under active surveillance without radiographic evidence of active disease. This case highlights the potential for prolonged survival in selected patients with recurrent\/metastatic ACC through iterative multidisciplinary decision-making, medical management, and repeat metastasectomy when feasible.<\/jats:p>","DOI":"10.1210\/jcemcr\/luag254","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:46:39Z","timestamp":1787139999000},"source":"Crossref","is-referenced-by-count":1,"title":["A decade of survival in recurrent nonfunctioning oncocytic adrenocortical carcinoma in a young Filipina"],"prefix":"10.1210","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5607-9821","authenticated-orcid":false,"given":"Ranee Joy","family":"Jacobo","sequence":"first","affiliation":[{"name":"Center for Diabetes, Thyroid, and Endocrine Disorders, St. Luke's Medical Center , Global City 1634 ,","place":["Philippines"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7065-8390","authenticated-orcid":false,"given":"Quennie Fae","family":"de Leon","sequence":"additional","affiliation":[{"name":"Center for Diabetes, Thyroid, and Endocrine Disorders, St. Luke's Medical Center , Global City 1634 ,","place":["Philippines"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0900-3803","authenticated-orcid":false,"given":"Patrick Wilson","family":"Lim","sequence":"additional","affiliation":[{"name":"Center for Diabetes, Thyroid, and Endocrine Disorders, St. Luke's Medical Center , Global City 1634 ,","place":["Philippines"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3796-5737","authenticated-orcid":false,"given":"Fidela Anne","family":"Badilles","sequence":"additional","affiliation":[{"name":"Center for Diabetes, Thyroid, and Endocrine Disorders, St. Luke's Medical Center , Global City 1634 ,","place":["Philippines"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1984-9277","authenticated-orcid":false,"given":"Patricia","family":"Maningat","sequence":"additional","affiliation":[{"name":"Center for Diabetes, Thyroid, and Endocrine Disorders, St. Luke's Medical Center , Global City 1634 ,","place":["Philippines"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"issue":"5","key":"2026091603525989600_luag254-B1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S2213-8587(24)00378-4","article-title":"Adrenocortical carcinoma: a practical guide for clinicians","volume":"13","author":"Fassnacht","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2026091603525989600_luag254-B2","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with ENSAT","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026091603525989600_luag254-B3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/106689690401200304","article-title":"Adrenocortical oncocytic tumors: report of 10 cases and review of the literature","volume":"12","author":"Bisceglia","year":"2004","journal-title":"Int J Surg Pathol"},{"issue":"1","key":"2026091603525989600_luag254-B4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12022-025-09857-0","article-title":"Oncocytic adrenocortical carcinoma: clinical and management insights","volume":"36","author":"Prinzi","year":"2025","journal-title":"Endocr Pathol"},{"issue":"4","key":"2026091603525989600_luag254-B5","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1210\/jc.2017-02591","article-title":"Mitotane monotherapy in patients with advanced adrenocortical carcinoma","volume":"103","author":"Megerle","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"21","key":"2026091603525989600_luag254-B6","doi-asserted-by":"crossref","first-page":"6925","DOI":"10.3390\/jcm12216925","article-title":"Prognosis of adrenal oncocytic neoplasms (AONs): literature review of 287 cases and presentation of the oldest patient","volume":"12","author":"Coppola Bottazzi","year":"2023","journal-title":"J Clin Med"},{"key":"2026091603525989600_luag254-B7","doi-asserted-by":"crossref","first-page":"781406","DOI":"10.3389\/fsurg.2022.781406","article-title":"Reoperation for recurrent adrenocortical carcinoma: a systematic review and pooled analysis","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Surg"},{"issue":"10","key":"2026091603525989600_luag254-B8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-8587(23)00193-6","article-title":"Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international multicentre, open-label, randomised phase 3 trial and observational study","volume":"11","author":"Terzolo","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2026091603525989600_luag254-B9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s40425-019-0722-x","article-title":"Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma","volume":"7","author":"Habra","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"5","key":"2026091603525989600_luag254-B10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1470-2045(24)00095-0","article-title":"Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial.","volume":"25","author":"Campbell","year":"2024","journal-title":"Lancet Oncol"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/10\/luag254\/71115221\/luag254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/10\/luag254\/71115221\/luag254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:53:03Z","timestamp":1789545183000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luag254\/8800982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9,3]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luag254","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,3]]},"article-number":"luag254"}}